Deep Track Capital, LP

Position in ORKA — Oruka Therapeutics, Inc.

CIK 1856083 GREENWICH, CT

Position in ORKA

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$183,297,420

+$83,519,763 QoQ

Shares Held

1,926,000

-5.3% QoQ

Ownership

2.91%

of shares outstanding

% of Portfolio

2.79%

of 13F equity value

Holder Rank

#10

of 254 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Deep Track Capital, LP holds $5,341,997,223 across 58 Biotechnology names. ORKA ranks #10 (3.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	IMVT	Immunovant, Inc.	9,341,151	$359,914,548
2	GPCR	Structure Therapeutics Inc.	4,740,072	$254,399,664
3	PCVX	Vaxcyte, Inc.	4,300,000	$249,959,000
4	ALNY	Alnylam Pharmaceuticals, Inc.	825,000	$248,349,750
5	MANE	Veradermics, Inc	2,000,000	$245,880,000
6	TARS	Tarsus Pharmaceuticals, Inc.	3,666,768	$230,786,377
7	OCUL	Ocular Therapeutix, Inc	19,686,282	$193,319,289
8	BMRN	Biomarin Pharmaceutical Inc	3,307,481	$189,254,062

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$183,297,420	1,926,000	-5.3%	Shares	Sole	2026-08-14
2026-03-31	$99,777,657	2,034,203	-5.9%	Shares	Sole	2026-05-15
2025-12-31	$65,515,368	2,161,510	-18.6%	Shares	Sole	2026-02-13
2025-09-30	$51,051,438	2,654,781	+38.4%	Shares	Sole	2025-11-14
2025-06-30	$21,509,725	1,918,798	+32.8%	Shares	Sole	2025-08-14
2025-05-06	$17,621,086	1,896,780	—	Shares	Sole	2025-05-13
2025-03-31	$14,822,714	1,444,709	+92.6%	Shares	Sole	2025-05-15
2024-12-31	$14,542,500	750,000	-39.3%	Shares	Sole	2025-02-14
2024-09-30	$30,274,433	1,235,187	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.